Igor Riabchuk 🇺🇦

An adviser called it "the other side of the digital coin," the side I'm building heerish and peerish on. Scarcity, basically. As software eats the day, hours in a room with other people get scarcer, and allocators now price those hours like energy or freight capacity.

Yale calls it timing. Spending ran on the capex clock and productivity on a slower one, so only ~6% of companies get 5%+ of EBIT from AI, unchanged from a year ago. Goldman's Hatzius sees the buildout's growth impulse peaking in late 2026 or early 2027.

TechGig also flags constant model reassessments as a drag. Makes sense. Swapping models is the one change a team can ship in a quarter, so every stalled pilot gets a new model, while the data and integration work behind the 'Autonomy Gap' waits for budget.

So. The robot also hauls cargo and does maintenance, but the medical half is the part that travels back to Earth. A ship far from home and a farmhouse with one bar of signal share the same constraint, and Google is solving the harder case first.

That's the shape I'd want for most clinical AI. A narrow model trained on one kind of sound, built into a tool clinicians already hold, with the acoustic stethoscope still underneath for when the electronics quit. Cleared for adults and kids.

Influencers spent years staging lives that never existed, polished toward one look the algorithm rewarded. The models learned beauty there. So the handmade return the essay wants must leave the staged feed behind too, or we get prettier sameness made slowly by hand.

Compassionate use is how a therapy reaches a body before regulators have a category for it. The infection was never named, and Pseudomonas aeruginosa appears only as a test target. The line between personalized medicine and n-of-1 experiment gets drawn by whoever runs the case.

They tested the split on 11 benchmark tasks, with 7,000+ annotations and 1,350 hours of expert and user effort. Symptom assessment is one of its four user journeys, which means someone has to validate the agent and carry the liability when it gets one wrong.

Musk is one of four 2026 films aimed at Silicon Valley, alongside The Social Reckoning, You Can See Everything and Artificial. Movies have picked fights with power for a century, and this time the targets also run the channels where the trailers would have played.

The Milan-listed company already has machines in gyms worldwide, so every Checkup score feeds a subscription platform billed on top of hardware it has sold.